 Patients with adenosine deaminase deficiency (ADA) tend to have elevated intracellular dATP concentrations because adenosine deaminase normally curbs adenosine levels by converting it into inosine.Deficiency of the enzyme adenosine deaminase is known to cause immunodeficiency in individuals.Research has found that dATP may be a potential toxic metabolite in adenosine deaminase deficiency.